Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Responsiveness of BASS in Knee Osteoarthritis
NCT03570554Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (4 arms), sponsored by Bayer. Primary endpoint: Sum of Change in Brief Arthritis Stiffness Scale (BASS) Scores Over the 4-day Treatment Period. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03570554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570554.